Trade Vir Biotechnology VIR

VirBiotechnology live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Aug 08, 05:12

Vir Biotechnology (NASDAQ:VIR) Stock Rating Upgraded by Wall Street Zen

Vir Biotechnology Inc
Webhose 2026 Aug 07, 15:56

Vir Biotechnology (NASDAQ:VIR) Posts Earnings Results, Beats Expectations By $0.14 EPS - Zolmax

Vir Biotechnology Inc
Webhose 2026 Aug 06, 07:03

Vir Biotechnology Q2 Earnings Call Highlights

Vir Biotechnology Inc
Webhose 2026 Aug 06, 05:08

Vir Biotechnology Inc (VIR) (Q2 2026) Earnings Call Highlights: 88% HDV Cure Rate and a $1B ...

Vir Biotechnology Inc
Webhose 2026 Aug 05, 22:11

Vir Biotechnology (NASDAQ:VIR) Posts Quarterly Earnings Results, Beats Estimates By $0.14 EPS

Vir Biotechnology Inc
Webhose 2026 Aug 05, 08:56

Renaissance Technologies LLC Increases Stake in Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc
Webhose 2026 Aug 01, 00:59

950,000 Shares in Vir Biotechnology, Inc. $VIR Bought by Avidity Partners Management LP - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jul 29, 11:26

Vir Biotechnology (VIR) Expected to Post Earnings on Wednesday

Vir Biotechnology Inc
Webhose 2026 Jul 29, 07:12

ADAR1 Capital Management LLC Invests $24.59 Million in Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc
Webhose 2026 Jul 29, 04:27

Vir Biotechnology (VIR) Expected to Announce Earnings on Wednesday - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jul 28, 10:34

Eversept Partners LP Takes $2.24 Million Position in Vir Biotechnology, Inc. $VIR - Zolmax

Vir Biotechnology Inc
Webhose 2026 Jul 28, 07:53

Empyrean Capital Partners LP Invests $4.73 Million in Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc
Webhose 2026 Jul 24, 13:01

Vir Biotechnology (NASDAQ:VIR) Shares Gap Down - What's Next? - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jul 23, 10:30

Monashee Investment Management LLC Makes New Investment in Vir Biotechnology, Inc. $VIR - Markets Daily

Vir Biotechnology Inc
Webhose 2026 Jul 23, 06:30

Monashee Investment Management LLC Takes Position in Vir Biotechnology, Inc. $VIR - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jul 17, 04:15

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jul 13, 08:28

Vir Biotechnology, Inc. $VIR Shares Acquired by Candriam S.C.A. - Zolmax

Vir Biotechnology Inc
Webhose 2026 Jul 13, 07:52

Vir Biotechnology, Inc. $VIR Shares Bought by Candriam S.C.A.

Vir Biotechnology Inc

VirBiotechnology News

number1 2025 Dec 05, 00:01

Pimco's Triumph in 2025: A Bold Bond Strategy Pays Off

number1 2025 Dec 04, 00:00

Fed Independence on the Line? Political Influence in 2026

number1 2025 Dec 04, 00:00

US Holiday Shopping Season: Record Online Sales Amid Economic Vulnerabilities

number1 2025 Dec 03, 00:00

US Economic Outlook 2026: A Roubini Analysis

number1 2025 Dec 02, 00:01

Fed's Divergent Votes: A Sign of Policy Uncertainty?

Frances Wang 2024 Dec 29, 16:00

Trading wisdom: how can I improve myself as a trader?

Frances Wang 2024 Dec 26, 16:00

Can you trade CFDs on crypto: platform to trade cryptocurrency CFDs

Frances Wang 2024 Dec 25, 16:00

EQV stock price today: Is EQV Ventures a good investment?

Frances Wang 2024 Dec 25, 16:00

How to start investing in dividend ETFs: 7 Dividend ETFs to Watch

Frances Wang 2024 Dec 23, 16:00

TSLQ ETF price forecast: How to track TSLQ ETF prices?

Latest news

Show more
number1 2026 Mar 14, 00:00

Russia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict

number1 2026 Mar 14, 00:00

US Economic Signals: Inflation Concerns and Growth Challenges

number1 2026 Mar 14, 00:00

Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions

number1 2026 Mar 14, 00:00

Apple Slashes App Store Commissions in China for Developers

number1 2026 Mar 14, 00:00

Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis

number1 2026 Mar 13, 12:07

Aussie Dollar Sees Surge in Bullish Bets Ahead of Reserve Bank of Australia Rate Decision

number1 2025 Dec 06, 00:00

India's Silver Demand Surge: New Loan Framework Boosts Market

number1 2025 Dec 04, 00:00

ADP Employment Data and the Fed's Policy Path: A Closer Look

Info

Spread

0.07

Spread (%)

0.7901 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

13:31 - 19:59

Monday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1492484608

Shares Outstanding

169215958

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-1.77

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Oil price jumps after Biden's comments on possible Israeli strikes on Iran
2024 Oct 05, 09:45

Migration Education Article Test

Trustpilot